How unusual is it for CD34+ donor cells to drop from 86% to 0% in 3 months

Understanding Your CD34+ Cell Drop: What This Means

This is an important question, and I can help you understand what's happening with your donor cells. Let me break this down in the context of your MDS and what you've been through.

What CD34+ Cells Are and Why They Matter

CD34+ cells are hematopoietic stem cells — essentially the "master cells" that create all your blood cells (red cells, white cells, platelets). In a stem cell transplant context, these are the cells from your donor that "take over" and rebuild your immune and blood system.

When you had your transplant, the 86% CD34+ measurement likely indicated excellent engraftment — meaning the donor cells were successfully establishing themselves and multiplying in your bone marrow.

Is a Drop to 0% Unusual? Yes — And This Needs Clarification

A complete disappearance of donor CD34+ cells in 3 months is NOT typical and suggests one of several possibilities:

1. Graft failure or rejection — your body's immune system rejected the donor cells
2. Graft loss — the donor cells initially engrafted but then were lost
3. Testing/measurement issue — the cells may still be present but weren't detected in that particular test
4. Different cell population being measured — the second test may have measured a different subset of cells

Critical Questions for Your Medical Team

This finding is significant enough that you should ask your transplant team specifically:

1. "What does the 0% CD34+ result actually mean? Does this indicate graft failure, or could it be a testing issue?"
2. "What other engraftment markers are you monitoring (chimerism studies, donor-derived cells, other CD markers)?" — Your team tested CD3, CD4, CD5, CD7, and CD2, which are important immune markers. How are THOSE looking?
3. "If graft loss occurred, what's the plan? Do I need intervention?"
4. "Are you seeing signs of engraftment in other ways — like recovery of blood counts, immune function, or donor chimerism?"

Why This Matters for Your MDS

According to NCCN Guidelines for Myelodysplastic Syndromes, allogeneic stem cell transplant is a potential curative approach for MDS, particularly for patients with your risk profile (IPSS-M moderate-low). However, the success of transplant depends entirely on sustained engraftment of donor cells.

If donor cells are truly absent, this could affect:

• Your blood cell recovery
• Your immune reconstitution
• Your long-term disease control

What You Should Do Now

Don't wait on this. Reach out to your transplant team and ask them to:

1. Explain the 0% result in plain language
2. Show you the actual test report (chimerism studies, flow cytometry results)
3. Clarify whether this represents true graft loss or a measurement artifact
4. Outline next steps if intervention is needed

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Your transplant physician has the complete clinical picture and can interpret these results in context of your overall recovery. This is definitely worth a direct conversation with them.